Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.
about
Adjuvant chemotherapy for rectal cancer: Is it needed?Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancerAnal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial.Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial.Revised TN categorization for colon cancer based on national survival outcomes data.Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomesCapecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04Entire-volume serial histological examination for detection of micrometastases in lymph nodes of colorectal cancersRisk groups defined by Recursive Partitioning Analysis of patients with colorectal adenocarcinoma treated with colorectal resectionPhysicians' beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancer.Patterns of lymph node metastasis are different in colon and rectal carcinomas.Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297.Rectal cancer treatment: improving the picture.Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients.In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer.Outcomes of rectal cancer with liver oligometastasesImpact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery.Locally advanced rectal cancer: the importance of a multidisciplinary approach.Patterns of local recurrence in rectal cancer after a multidisciplinary approach.Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population.Recent advances in the management of carcinoma of the rectumThe role of tissue diagnosis prior to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched AnalysisSpecific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancerNeoadjuvant treatment in rectal cancer: actual status.A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas.Advances and challenges in treatment of locally advanced rectal cancer.Do all locally advanced rectal cancers require radiation? A review of literature in the modern era.Getting knit-PI3Ky: PIK3CA mutation status to direct multimodality therapy?Sequential PET/CT with [18F]-FDG Predicts Pathological Tumor Response to Preoperative Short Course Radiotherapy with Delayed Surgery in Patients with Locally Advanced Rectal Cancer Using Logistic Regression AnalysisTreatment of locally advanced rectal cancer: controversies and questions.ACR appropriateness criteria® resectable rectal cancerTransanal excision with radiation therapy for rectal adenocarcinoma.Total mesorectal excision for the treatment of rectal cancer.Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I-II studyDoes Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience.Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapy.
P2860
Q26775099-27C52773-2777-4904-88FD-4951E780E288Q26796352-A5F4C068-BA90-4DB3-B8C8-5B80C1BD7870Q30409533-FFAFC2CE-2E96-4E4E-930C-0181CBC5E054Q33438899-22E180B1-BCCC-41A4-8F86-FE2DBA266027Q33516922-101CA702-6E80-49FF-A0A5-9E9E045A128EQ33627785-32581464-C498-4728-A917-3F7CB43BE6FFQ33729092-2B556F4B-8191-411E-85E3-691ABBB9E8B9Q33980405-470F575A-77EF-4FE4-99D5-8E3D0163F1DFQ34116220-6BCEEEA2-3901-4A3A-8C18-123BDA04C4A6Q34168211-27520724-1D58-45E4-BC46-778D026E87E8Q34306792-4341BF8A-21E5-4DE7-8F3E-ADE9AF691324Q34344547-F96D0144-C96C-4E97-8019-F426BE1077B4Q34382761-FD78474D-2FC7-4814-A59E-D592C1CE92C7Q34437609-F717D4E6-414F-4ACA-8152-854FBB9F1F5BQ34469631-9E2E3E3D-40C0-4C67-9462-4E1E3EB4FFE3Q34484282-48390E7C-E7A1-443B-9F5D-2DBD9A40FDBCQ34687101-BD1CBE32-C07D-4625-9B84-38DDFD3F5368Q34696515-6BB01761-2E02-4EDD-9479-BF6C343DC39CQ34771979-294E24B3-E1E4-4189-AD7A-D2F2E0458487Q34898391-4E717BF3-1ABF-4682-801F-B3A64550A72CQ35011194-ACE08192-1CAD-48F1-9D18-C184CB5C06C6Q35026254-28BE9AB4-E7FA-46AE-9646-03C4F078F1B2Q35160866-58CFB769-F1AD-4131-A5A1-BC342E101D8DQ35445092-38652829-095C-4B18-BEC5-87CF9EB6E2A5Q35526932-33A00B04-7553-4287-B772-E4102CF6C081Q35653762-00CB3CEF-62DE-4789-AD1C-4EC8C2B52D47Q35687452-2C9EA8F7-8E2F-4010-B853-2D0077B427FAQ35993810-C7684DD2-5E89-43B2-BBB1-37418FF08A7FQ36025983-BF352624-D989-4DDB-852B-185734D87279Q36097082-013370B9-F485-4577-95F8-ED35C6CFA985Q36104000-B5AB861D-33D1-42D9-8E37-EFA110C0DE73Q36242706-266A7E34-804F-4BF4-8BE1-439AADDC311AQ36351882-C26864F1-4DF0-4040-B057-AAD11F8446B7Q36371152-E51620C3-7984-4FBF-A8A1-A1D48BACF47DQ36388243-87C4453C-F2F0-4F9B-85F7-0A3299BBB3A6Q36497995-9C38A937-7A51-481B-8E55-15BA20DAC95EQ36540452-9ED28320-FEE6-434D-B4AB-2FA717FCB3B3Q36614369-74D940A1-8693-4E26-9495-4A34CB161183Q36880544-FFB91D1C-79F8-4E16-B1FD-B2A58EB7B6C3Q36913615-CED07332-2D47-4C92-A497-8960003A669B
P2860
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Impact of T and N stage and tr ...... tal cancer: a pooled analysis.
@ast
Impact of T and N stage and tr ...... tal cancer: a pooled analysis.
@en
Impact of T and N stage and tr ...... tal cancer: a pooled analysis.
@nl
type
label
Impact of T and N stage and tr ...... tal cancer: a pooled analysis.
@ast
Impact of T and N stage and tr ...... tal cancer: a pooled analysis.
@en
Impact of T and N stage and tr ...... tal cancer: a pooled analysis.
@nl
prefLabel
Impact of T and N stage and tr ...... tal cancer: a pooled analysis.
@ast
Impact of T and N stage and tr ...... tal cancer: a pooled analysis.
@en
Impact of T and N stage and tr ...... tal cancer: a pooled analysis.
@nl
P2093
P356
P1476
Impact of T and N stage and tr ...... ctal cancer: a pooled analysis
@en
P2093
Christopher G Willett
Cristine Allmer
Daniel G Haller
Jaffer A Ajani
James A Martenson
Joel E Tepper
John S MacDonald
Leonard L Gunderson
Linda Colangelo
Michael J O'Connell
P304
P356
10.1200/JCO.2004.08.173
P407
P577
2004-04-05T00:00:00Z